Article
Compounded or brand: what the difference costs
Across 699 programs publishing a cash price, the median compounded program asks $199 a month and the median brand program $371.50 — a difference of $173. The gap is real, and it is not the whole story: the two are different products, bought under different rules.
Computed from the register, as of September 13, 2026
Contents
Reading
They are not the same product
A brand GLP-1 is a manufactured medicine sold under a name you will recognize. A compounded one is prepared by a pharmacy, and the register records 593 programs selling one against 106 selling the other at a cash price. Reading the two figures below as a discount on the same thing is the single easiest mistake to make in this market.
What the difference costs
Median compounded (593 programs)
$199
Median brand (106 programs)
$371.50
Brand as a multiple
1.9×
Both figures are the cheapest unconditional price each program publishes at its shortest term, so they answer the same question of every company.
The two are not spread alike, and the medians alone hide it. Half of the compounded programs sit between $149 and $255. Half of the brand programs sit between $200 and $1,299 — a range several times wider, because brand pricing runs from a discounted manufacturer program up to the full list price of the medicine.
699 matched · 717 programs with a cash price assessed · 27 not yet checked · 858 entries in the register
⛔ Two groups sit outside that comparison and are counted rather than folded into it. 62 62 programs selling Unspecified GLP-1 at a median of $153; 52 52 programs selling Oral semaglutide at a median of $199. An oral preparation and a program that names no molecule at all are each their own question, and averaging them into either family above would answer neither.
Insurance changes the question entirely
18 18 programs in the register lead with a figure that depends on a reader having coverage — a copay rather than a cash price, sometimes as low as $25 a month. Those are set aside above, and the reason matters more than the arithmetic.
A copay is the number a reader is least likely to pay and the number most likely to win a comparison, because it is the smallest one on the page. It depends on the plan, on whether the plan covers weight management at all, and on a deductible the company usually mentions in the same sentence. Where a program publishes one, the entry records it and shows it — it simply is not treated as the program's price. If a brand program is within reach for you, coverage is the thing to establish first, because it moves the figure further than any choice of company will.
What to establish before you compare
- Which is it? A program advertising a low monthly figure for a GLP-1 is, in this register, usually selling a compounded preparation.
- Is the figure a cash price or a copay? If it depends on insurance, it is not comparable with a cash price from another company.
- Does the price include the medication? Several brand programs sell a membership and let the manufacturer bill for the drug separately.
Every figure here is computed from the 858 entries in this register when the page is built, across 363 companies, and each one links back to the company's own sentence and the date it was read. The register is browsable and the data is downloadable.
Notes
Cite this
Treatment Registry. (2026). Compounded or brand: what the difference costs. Retrieved [your access date], from https://treatmentregistry.com/articles/compounded-or-brand-what-the-difference-costs